China Advertising Law Compliance Checklist: Pre-Publication Review for Foreign Marketers
Before publishing any advertisement in China, foreign marketers must verify at least 14 critical compliance checkpoints under the Advertising Law of the People’s Republic of China (中华人民共和国广告法, Advertising Law, Zhōnghuá Rénmín Gònghéguó Guǎnggào Fǎ). Failure to do so can result in fines of up to RMB 1,000,000 (approximately USD 140,000) and forced removal of the advertisement. With enforcement actions increasing by 37% year-over-year in 2024 and the average fine per violation rising to RMB 180,000, a structured pre-publication review is no longer optional—it is essential for market entry success. The law applies across all media, including social posts, e-commerce listings, print ads, and video content.
1. Content Prohibitions: Absolute Language and Comparative Claims
The Advertising Law strictly bans “absolute language” (绝对化用语, juéduìhuà yòngyǔ)—words like “best,” “first,” “national,” “most,” and “only”—unless the claim can be proven with authoritative documentation. Even seemingly minor phrases such as “industry leader” or “top-tier quality” can trigger penalties if unsupported. Fines for absolute language violations range from RMB 200,000 to RMB 1,000,000, and the advertiser bears the full burden of proof. Comparative advertising is permitted only when claims are factual, non-disparaging, and verifiable. For example, comparing ingredient concentration against a competitor requires a third-party lab report. Foreign marketers often overlook that even translated claims from home-market ads must be re-evaluated for Chinese law compliance—what is acceptable in the US or EU may automatically violate Article 9 of the Advertising Law.
2. Evidence and Substantiation Requirements
Every performance, efficacy, or quality claim in a Chinese advertisement must be supported by documentary evidence. This applies to data, test results, certifications, awards, and customer testimonials. The burden of proof falls entirely on the advertiser: if a regulator requests evidence and you cannot produce it within the specified timeline (usually 15 days), the ad is presumed false. False advertising penalties are severe: fines of 3 to 5 times the advertising cost, or RMB 200,000 to RMB 2,000,000 if the cost cannot be calculated. For health-related claims (e.g., “boosts immunity,” “improves skin hydration”), specific approvals from the China Food and Drug Administration (国家药品监督管理局, NMPA, Guójiā Yàopǐn Jiāndū Guǎnlǐ Jú) or the State Administration for Market Regulation (国家市场监督管理总局, SAMR, Guójiā Shìchǎng Jiāndū Guǎnlǐ Zǒngjú) are required. Marketers should maintain a compliance binder with original certificates, lab reports, and translations ready for inspection.
3. Special Category Regulations and Pre-Approval
Certain product categories require pre-publication approval from SAMR or its provincial bureaus. These include: pharmaceuticals, medical devices, pesticides, veterinary drugs, health foods (保健食品, health food, bǎojiàn shípǐn), and alcohol. For health foods, the advertisement must include the mandatory disclaimer: “This product is not a substitute for medicine” (本品不能代替药物). Alcohol ads cannot appeal to minors, imply health benefits, or associate drinking with driving. Pre-approval timelines vary: health food ads typically take 20–30 working days, while pharmaceutical ads can take 30–60 working days. Operating without pre-approval in these categories carries fines of up to RMB 500,000 plus seizure of advertising materials. Foreign brands often underestimate these lead times, resulting in delayed campaign launches.
Pre-Publication Compliance Checklist
| Checkpoint | Requirement | Risk Level | Penalty Range |
|---|---|---|---|
| Absolute language (e.g., “best”) | No unprovable superlatives | High | RMB 200,000–1,000,000 |
| Comparative claims | Must be factual, non-disparaging | Medium | RMB 100,000–500,000 |
| Testimonials and endorsements | Must be genuine, signed consent | High | RMB 200,000–1,000,000 |
| Data and statistics | Cite authoritative sources | Medium | RMB 100,000–500,000 |
| Health claim (food/cosmetics) | Pre-approval required | High | Up to RMB 500,000 |
| Alcohol advertising | No appeal to minors, no health claims | Medium | RMB 100,000–300,000 |
| Patent claims | List patent number and type | Low | RMB 50,000–200,000 |
| Performance claim (e.g., durability) | Test report from accredited lab | Medium | RMB 100,000–500,000 |
| Testimonial with real person | Signed authorization form | Medium | RMB 100,000–200,000 |
| Social media disclosure | Label paid promotion clearly | High | RMB 100,000–1,000,000 |
| E-commerce listing accuracy | Match packaging and approvals | Medium | RMB 100,000–500,000 |
| Video/influencer content | Include #ad or #sponsored tag | High | RMB 100,000–300,000 |
| Translated slogan or tagline | No implied claims not in original | Medium | RMB 100,000–500,000 |
| Children’s products (age 14 and under) | No inducement to purchase, no exaggerated claims | High | RMB 200,000–1,000,000 |
4. Platform and Format Compliance
Beyond national law, each digital platform imposes its own advertising rules. Douyin (抖音) requires clear labeling of paid partnerships and bans medical efficacy claims for cosmetics. WeChat Official Accounts must mark commercial content as “advertisement” (广告) at the top of the post. Xiaohongshu (小红书) mandates that sponsored posts include the tag “paid partnership with [brand name].” E-commerce platforms like Taobao and JD.com require listing descriptions to match approved packaging text exactly. Failure to meet platform-specific rules can result in ad removal, account suspension, or fines imposed jointly by the platform and SAMR. In 2024, 45% of advertising violations by foreign brands occurred on social media and influencer channels, making platform compliance a high-priority checkpoint.
Decision Framework for Pre-Publication Review
If your advertisement makes a health or efficacy claim, obtain pre-approval from the provincial SAMR or NMPA at least 30 working days before publication. If your advertisement uses performance data or statistics, prepare supporting test reports from a CNAS-accredited laboratory and keep originals ready for regulator inspection. If your advertisement runs on Douyin, Xiaohongshu, or WeChat, add platform-specific disclosures and confirm the content complies with each platform’s advertising policy. If your advertisement targets children under 14, avoid any content that induces purchase or contains exaggerated product benefits—this category faces the strictest scrutiny.
3 Common Compliance Pitfalls
NEXT STEPS
- Read our full guide: China Advertising Law Guide for Foreign Brands — a 5,000-word deep dive into Articles 9, 17, and 28 with case examples.
- Review platform-specific requirements: WeChat Advertising Compliance Checklist — detailed rules for Official Accounts, Mini Programs, and Moments ads.
- Consult with a licensed advertising review agency: Pre-Publication Review Services — professional review of your ad content against SAMR standards, with a 48-hour turnaround.
— China Gateway 360 —
Remote China market entry support, built around execution.
